Brett J

St Vincent's Clinical School (J.B.), University of New South Wales, Sydney, New South Wales, Australia.

10 papers · ORCID

ArticlePsilocybin

Large-Scale and Local Functional Connectivity Changes following Psilocybin Administration in Methamphetamine Use Disorder.

Chaganti J, Siefried KJ, Vyakaranam VS +2

Europe PMC2026
ArticlePsychedelics

Editorial: Emerging treatment approaches for substance use disorders.

Martinez Garza D, Blokhin IO, Brett J +1

Europe PMC2026
ArticleKetamine

Navigating 'k-land': a qualitative exploration of participants' experiences of ketamine-assisted psychotherapy for methamphetamine use disorder.

Fletcher K, Ezard N, Siefried KJ +6

Europe PMC2026
ArticlePsilocybin

A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorder.

Brett J, Lea T, Knock E +4

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.

Knock E, Siefried KJ, Bedi G +6

Europe PMC2025
ArticlePsychedelics

Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international survey.

Bahceci D, Siefried K, Steele M +9

Europe PMC2025
ArticleKetamine

Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychothera<u>p</u>y for methamphetamine use disorder (the KAPPA trial).

Fletcher K, Ezard N, Siefried KJ +11

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.

Brett J, Knock E, Watson K +3

Europe PMC2024
ArticlePsilocybin

The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.

Wilkes R, Roberts DM, Liknaitzky P +1

Europe PMC2024
ArticlePsilocybin

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.

Brett J, Knock E, Korthuis PT +5

Europe PMC2023